Remove Definition Remove Regulations Remove Treatment Remove Vaccine
article thumbnail

Article FDA Thank You FDA gives companies leeway to go after misinformation, but not free reign

Agency IQ

BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products. The FDA is responsible for ensuring that medical products are adequately labeled in accordance with federal regulations, including the product’s “intended use” and relevant safety information.

FDA 40
article thumbnail

Treatment Plans That Worked

The Pharma Data

Product Name: Treatment Plans That Worked. Click here to get Treatment Plans That Worked at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Order 576 Treatment Plans That Worked here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article EMA Thank You MHRA selects eight technologies to help it test its new innovative devices pathway

Agency IQ

MHRA selects eight technologies to help it test its new innovative devices pathway The British regulator and its partners just released the list of products and companies chosen to participate in the pilot of its Innovative Device Access Pathway (IDAP). device regulations and the pilot for innovative products. Life Sciences Vision.

article thumbnail

Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

The Pharma Data

The vaccine supply for the EU would be produced by BioNTech’s manufacturing sites in Germany and Pfizer’s manufacturing site in Belgium. The proposed supply agreement with the European Commission would represent the largest initial order of vaccine doses for Pfizer and BioNTech to date. billion doses by the end of 2021.

Vaccine 52
article thumbnail

Janssen Announces Treatment with ERLEADA

The Pharma Data

Janssen Announces Treatment with ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer. ERLEADA ® is an androgen receptor (AR) inhibitor indicated for the treatment of patients with nmCRPC and for the treatment of patients with mCSPC. 10 months. [5]

article thumbnail

Article EMA Thank You EMA publishes Union list of critical medicines

Agency IQ

A 2017 European Parliament resolution called on the European Commission and the European Council “to formulate a better definition of the concept – and analyse the causes – of shortages of medicines.” Regulation (EU) 2022/123 became applicable on March 1, 2022, with the exception of most provisions related to medical devices.

article thumbnail

Analysis Chemical Thank You PFOA and PFOS designated as hazardous substances under Superfund

Agency IQ

However, other groups, like the Organisation for Economic Co-operation and Development (OECD), have also issued their own definitions for PFAS. These dangers included several adverse human health effects, such as high cholesterol, changes in liver enzymes, decreased immune response to vaccination, thyroid disorders, and cancer.